Choosing the optimal fit function: Comparison of the Akaike information criterion and the F-test

被引:206
作者
Glatting, Gerhard [1 ]
Kletting, Peter
Reske, Sven N.
Hohl, Kathrin
Ring, Christina
机构
[1] Univ Ulm, Klin Nukl Med, D-89070 Ulm, Germany
[2] Univ Ulm, Inst Biometrie, D-89070 Ulm, Germany
关键词
Akaike information criterion; F-test; fit function; blood pharmacokinetics;
D O I
10.1118/1.2794176
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
In many circumstances of data fitting one has to choose the optimal fitting function or model among several alternatives. Criteria or tests on which this decision is based are necessary and have to be well selected. In this preliminary analysis the application of the corrected Akaike information criterion is demonstrated considering the example of determining pharmacokinetic parameters for the blood serum time activity curves of In-111-labeled anti-CD66 antibody. Another model selection criterion, the F-test, is used for comparison. For the investigated data the corrected Akaike information criterion has proved to be an effective and efficient approach, applicable to nested and non-nested models. (C) 2007 American Association of Physicists in Medicine.
引用
收藏
页码:4285 / 4292
页数:8
相关论文
共 19 条
[1]
Akaike H., 1973, 2 INT S INFORM THEOR, P267, DOI [DOI 10.1007/978-1-4612-1694-0_15, 10.1007/978-1-4612-1694-0_15]
[2]
Belsley D. A., 1980, REGRESSION DIAGNOSTI
[3]
Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome:: results of a phase I-II study [J].
Bunjes, D ;
Buchmann, I ;
Duncker, C ;
Seitz, U ;
Kotzerke, J ;
Wiesneth, M ;
Dohr, D ;
Stefanic, M ;
Buck, A ;
Harsdorf, SV ;
Glatting, G ;
Grimminger, W ;
Karakas, T ;
Munzert, G ;
Döhner, H ;
Bergmann, L ;
Reske, SN .
BLOOD, 2001, 98 (03) :565-572
[4]
Burnham K.P., 2002, Model selection and multimodel inference: a practical information-theoretic approach, DOI 10.1007/978-1-4757-2917-7_3
[5]
Glatting G, 2006, NUKLEARMED-NUCL MED, V45, P134
[6]
Internal radionuclide therapy: The ULMDOS software for treatment planning [J].
Glatting, G ;
Landmann, M ;
Kull, T ;
Wunderlich, A ;
Blumstein, NM ;
Buck, AK ;
Reske, SN .
MEDICAL PHYSICS, 2005, 32 (07) :2399-2405
[7]
Treatment of radioactive decay in pharmacokinetic modeling:: Influence on parameter estimation in cardiac 13N-PET [J].
Glatting, G ;
Reske, SN .
MEDICAL PHYSICS, 1999, 26 (04) :616-621
[8]
HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663
[9]
EFFICIENCY OF DIFFERENT CRITERIA FOR SELECTING PHARMACOKINETIC MULTIEXPONENTIAL EQUATIONS [J].
IMBIMBO, BP ;
MARTINELLI, P ;
ROCCHETTI, M ;
FERRARI, G ;
BASSOTTI, G ;
IMBIMBO, E .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1991, 12 (02) :139-147
[10]
MAZEROLLE MJ, 2004, THESIS U LAVAL CANAD